Jpmorgan Chase & CO Schedule 13G passive stakes

JPMorgan Chase & Co. has filed a Schedule 13G, disclosing beneficial ownership of 4.9% of Lamb Weston Holdings, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 38,598,106 shares, representing 7.4% of 3M Company's common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 7.6% of Warner Music Group Corp.'s Class A Common Stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 8.7% of Ventas, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has reported a significant beneficial ownership stake of 8.0% in Twilio Inc.'s Class A Common Stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Trane Technologies PLC's ordinary shares as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.6% of NXP Semiconductors N.V. common shares as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 6.3% of Neurocrine Biosciences, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.0% of Lemonade, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Fidelity National Information Services, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 13.0% of DigitalOcean Holdings, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting a beneficial ownership of 9.8% in Burlington Stores, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has updated its Schedule 13G filing, reporting beneficial ownership of 6.9% of Baker Hughes Company's Class A Common Stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 7.5% of AutoZone, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 5.5% of Arthur J. Gallagher & Co. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of 10.4% of Andersen Group Inc.'s Class A common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed an amended Schedule 13G, reporting beneficial ownership of McDonald's Corporation common stock.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.7% of Insmed Incorporated's common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 18,118,656 shares, representing 4.5% of Howmet Aerospace Inc.'s common stock.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.3% of Healthpeak Properties, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of Hayward Holdings, Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.8% of CSLM Digital Asset Acquisition Corp III, Ltd.'s Class A ordinary shares.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 3.3% of Cerebras Systems Inc. Class A common stock as of June 30, 2026.

JPMorgan Chase & Co. has reported a beneficial ownership of 4.8% in Cartesian Therapeutics, Inc., holding 1,486,252 shares.

JPMorgan Chase & Co. has filed a Schedule 13G, reporting beneficial ownership of 4.4% of Willscot Holdings Corporation's common stock as of June 30, 2026.

JPMorgan Chase & Co. has reported beneficial ownership of 5.0% of Chipotle Mexican Grill Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has reported a 5.0% beneficial ownership in Kulicke & Soffa Industries Inc. common stock as of June 30, 2026.

JPMorgan Chase & Co. has reported a 5.0% ownership stake in MKS Inc. as of June 30, 2026.

JPMorgan Chase & Co. has reported beneficial ownership of over 14.4 million shares, representing 5.1% of Ecolab Inc.'s common stock.

JPMorgan Chase & Co. has reported beneficial ownership of 5.2% of LB Pharmaceuticals Inc.'s common stock as of June 30, 2026.